Biocon Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Biocon Quarterly Results    (BICN)

Here are the latest quarterly results of Biocon. For more details, see the Biocon financial fact sheet and Biocon share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Biocon Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-18
*
3
Sep-18
*
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m11,23813,21015,4087,6394,80815,72217,48115,810 
Other income Rs m688544256139253384358631 
Turnover Rs m11,92613,75415,6647,7785,06116,10617,83916,441 
Expenses Rs m8,8609,81411,6016,6544,07411,69413,03912,624 
Gross profit Rs m2,3785,2843,8659851,5544,7034,4423,186 
Depreciation Rs m9911,1221,1673752401,3161,4401,524 
Interest Rs m17618818665138177168 
Profit before tax Rs m1,8994,5182,7687431,5623,6333,1832,125 
Tax Rs m521732461383421,001848450 
Profit after tax Rs m1,3783,7862,3077051,2202,6322,3351,675 
Gross profit margin %21.240.025.112.932.329.925.420.2 
Effective tax rate %27.416.216.75.121.927.626.621.2 
Net profit margin %12.328.715.09.225.416.713.410.6 
Diluted EPS Rs 2.3 6.3 3.8 1.2 2.0 4.4 3.9 2.8  
Diluted EPS (TTM) Rs 7.3 12.6 15.0 13.6 13.4 11.4 11.5 13.1  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Biocon 3QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   WYETH  TORRENT PHARMA  ORCHID PHARMA  ALEMBIC PHARMA  SUVEN LIFESCIENCES  

Compare BIOCON With:   WYETH  TORRENT PHARMA  ORCHID PHARMA  ALEMBIC PHARMA  SUVEN LIFESCIENCES  

Compare BIOCON With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Snap 4-Day Winning Streak; Smallcap Stocks Outperform(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended marginally lower.

Views on news

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

My Latest Stock Recommendation (Fast Profits Daily)

Oct 9, 2020

How I picked an exciting stock using trends from both the commodity and equity markets.

The 'Seedhi Baat, No Bakwaas' View on ITC (Profit Hunter)

Oct 12, 2020

Is ITC an investment or a speculation at current levels?

One of the Best Investment Opportunities in the Market Right Now (Fast Profits Daily)

Oct 16, 2020

The one sector that you should be looking at to make good profits.

The Inflection Point for Defence Stocks is Getting Closer (Profit Hunter)

Oct 9, 2020

Few Indian defence companies could use their engineering capabilities to eventually become global leaders.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Oct 22, 2020 (Close)

TRACK BIOCON

MORE ON BIOCON

BIOCON - ALEMBIC COMPARISON

COMPARE BIOCON WITH

MARKET STATS